English | Español
Patient Daily | Mar 22, 2026

Astellas ends partnership with CytomX despite positive early cancer drug data
Patient Daily | Mar 22, 2026

Rhythm’s Imcivree fails to meet main goal in late-stage obesity trial
Patient Daily | Mar 22, 2026

FDA issues third rejection for Aldeyra’s dry eye disease drug on March 17
Patient Daily | Mar 22, 2026

Federal judge blocks Kennedy’s vaccine policy overhaul, citing procedural failures
Patient Daily | Mar 22, 2026

FDA expands leucovorin use for rare disease amid scrutiny of regulatory standards
Patient Daily | Mar 22, 2026

Study links gut microbe molecules to coronary heart disease risk
Patient Daily | Mar 22, 2026

Binghamton University study links breakfast, exercise, and sleep to mental resilience
Patient Daily | Mar 22, 2026

Study reveals new dual role of ezrin in osteosarcoma

Trending
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Revolution and Ascendis identified as top buyout targets amid speculation of industry mega-merger